These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30287168)

  • 1. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.
    Ouyang H; Ma W; Zhang T; Liu F; Zhao L; Fang M; Quan M; Pan Z
    Pancreatology; 2018 Dec; 18(8):983-989. PubMed ID: 30287168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.
    Ouyang H; Ma W; Liu F; Yue Z; Fang M; Quan M; Pan Z
    Pancreatology; 2017; 17(5):773-781. PubMed ID: 28734721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases.
    Qiang WG; Shi LR; Li XD; Wu QQ; Zhao JM; Chen LJ; Yang Y; Wu J; Ji M; Wu CP
    Clin Transl Oncol; 2015 Nov; 17(11):870-5. PubMed ID: 26055340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases].
    Ouyang HH; Pan ZY; Ma WD; Zhao LJ; Zhang T; Liu F; Quan MM
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):425-30. PubMed ID: 26875916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
    He YF; Li YH; Zhang DS; Xiang XJ; Xu RH; Pan ZZ; Zhou ZW; Jiang WQ; He YJ; Wan DS
    Ai Zheng; 2006 Sep; 25(9):1153-7. PubMed ID: 16965661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer Registry.
    Kessler J; Singh G; Ituarte PHG; Allen R; Chang S; Li D
    J Vasc Interv Radiol; 2021 Mar; 32(3):393-402. PubMed ID: 33358144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of liver-directed therapy in colorectal cancer liver metastases.
    Vargas GM; Parmar AD; Sheffield KM; Tamirisa NP; Brown KM; Riall TS
    J Surg Res; 2014 Sep; 191(1):42-50. PubMed ID: 24990539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
    Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
    Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
    Gibbs P; Do C; Lipton L; Cade DN; Tapner MJ; Price D; Bower GD; Dowling R; Lichtenstein M; van Hazel GA
    BMC Cancer; 2015 Oct; 15():802. PubMed ID: 26503593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
    Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
    Falchook GS; Wolff RA; Varadhachary GR
    Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of inoperable liver metastases from colorectal cancer].
    Milandri C; Calzolari F; Giampalma E; Vagliasindi A; Bertagni A; Ridolfi L; Passardi A; Ridolfi R; Golfieri R; Verdecchia GM
    Tumori; 2003; 89(4 Suppl):112-4. PubMed ID: 12903565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.
    Ouyang H; Ma W; Jiang X; Gerdtsson AS; Liu D; Pan Z
    Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):405-412. PubMed ID: 36803208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
    DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
    Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.
    Zhang W; Yu Y; Fang Y; Wang Y; Cui Y; Shen K; Liu T
    Clin Transl Oncol; 2015 Nov; 17(11):888-94. PubMed ID: 26108406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.